1. Home
  2. SGHT vs MPA Comparison

SGHT vs MPA Comparison

Compare SGHT & MPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGHT
  • MPA
  • Stock Information
  • Founded
  • SGHT 2011
  • MPA 1992
  • Country
  • SGHT United States
  • MPA United States
  • Employees
  • SGHT N/A
  • MPA N/A
  • Industry
  • SGHT Medical Specialities
  • MPA Finance Companies
  • Sector
  • SGHT Health Care
  • MPA Finance
  • Exchange
  • SGHT Nasdaq
  • MPA Nasdaq
  • Market Cap
  • SGHT 140.1M
  • MPA 139.0M
  • IPO Year
  • SGHT 2021
  • MPA N/A
  • Fundamental
  • Price
  • SGHT $3.03
  • MPA $11.04
  • Analyst Decision
  • SGHT Buy
  • MPA
  • Analyst Count
  • SGHT 7
  • MPA 0
  • Target Price
  • SGHT $3.92
  • MPA N/A
  • AVG Volume (30 Days)
  • SGHT 161.2K
  • MPA 25.2K
  • Earning Date
  • SGHT 05-08-2025
  • MPA 01-01-0001
  • Dividend Yield
  • SGHT N/A
  • MPA 3.83%
  • EPS Growth
  • SGHT N/A
  • MPA N/A
  • EPS
  • SGHT N/A
  • MPA N/A
  • Revenue
  • SGHT $78,109,000.00
  • MPA N/A
  • Revenue This Year
  • SGHT N/A
  • MPA N/A
  • Revenue Next Year
  • SGHT $11.17
  • MPA N/A
  • P/E Ratio
  • SGHT N/A
  • MPA N/A
  • Revenue Growth
  • SGHT N/A
  • MPA N/A
  • 52 Week Low
  • SGHT $2.03
  • MPA $9.87
  • 52 Week High
  • SGHT $8.45
  • MPA $12.21
  • Technical
  • Relative Strength Index (RSI)
  • SGHT 56.13
  • MPA 54.61
  • Support Level
  • SGHT $2.81
  • MPA $10.99
  • Resistance Level
  • SGHT $3.26
  • MPA $11.13
  • Average True Range (ATR)
  • SGHT 0.24
  • MPA 0.12
  • MACD
  • SGHT -0.01
  • MPA 0.04
  • Stochastic Oscillator
  • SGHT 38.57
  • MPA 88.00

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.

About MPA Blackrock MuniYield Pennsylvania Quality Fund

Blackrock Muniyield Pennsylvania Quality Fund is a closed-end fund with investment objective is to provide shareholders with current income exempt from U.S. federal and Pennsylvania income taxes.

Share on Social Networks: